Kotake C, Ito Y, Yokoyama M, Fukuzaki H
Department of Internal Medicine, Kobe University School of Medicine, Japan.
Heart Vessels. 1987;3(2):84-90. doi: 10.1007/BF02058524.
An excess of thyroid hormone is known to produce cardiac dysfunction and failure, i.e., thyrotoxic heart. We studied the protective effect of coenzyme Q10 (CoQ10) on the thyrotoxic heart in 29 rabbits. A group treated with 1-thyroxine sodium salt (T4; 167 micrograms/kg) for 3 weeks showed marked decreases in the myocardial content of norepinephrine (NE) and ATP (0.5 +/- 0.2 microgram/g wet weight, P less than 0.05 and 31.1 +/- 2.6 nmol/mg protein, P less than 0.05, respectively) as compared with a group treated with CoQ10 solvent (2 ml/kg) for 3 weeks (1.1 +/- 0.1 microgram/g wet weight and 45.7 +/- 4.7 nmol/mg protein). The mitochondrial Ca2+ content of the T4 group showed significant increases (21.3 +/- 0.6 nmol/mg protein, P less than 0.05) compared with the solvent group (18.2 +/- 0.8 nmol/mg protein), while the total tissue Ca2+ content of the T4 group was unchanged compared with the solvent group. These biochemical derangements suggest that T4-treated rabbits were in a state of cardiac dysfunction. In contrast, a group which was assigned to concomitant treatment of T4 and CoQ10 (5 mg/kg) for 3 weeks showed no reductions in NE and ATP (0.9 +/- 0.2 micrograms/g wet weight and 44.6 +/- 1.9 nmol/mg protein, respectively) and protected an increase in the mitochondrial Ca2+ content (18.2 +/- 1.2 nmol/mg protein). A group treated with CoQ10 (5 mg/kg) for 3 weeks showed no changes in myocardial NE, ATP, and Ca2+ content in the mitochondria. These results suggest that exogenously administered CoQ10 may protect against biochemical derangements in the thyrotoxic heart.
已知甲状腺激素过量会导致心脏功能障碍和衰竭,即甲状腺毒症性心脏病。我们研究了辅酶Q10(CoQ10)对29只家兔甲状腺毒症性心脏病的保护作用。一组用1-甲状腺素钠盐(T4;167微克/千克)治疗3周,与用CoQ10溶剂(2毫升/千克)治疗3周的组相比,其心肌去甲肾上腺素(NE)和ATP含量显著降低(分别为0.5±0.2微克/克湿重,P<0.05和31.1±2.6纳摩尔/毫克蛋白,P<0.05)(1.1±0.1微克/克湿重和45.7±4.7纳摩尔/毫克蛋白)。与溶剂组(18.2±0.8纳摩尔/毫克蛋白)相比,T4组的线粒体Ca2+含量显著增加(21.3±0.6纳摩尔/毫克蛋白,P<0.05),而T4组的总组织Ca2+含量与溶剂组相比没有变化。这些生化紊乱表明,用T4治疗的家兔处于心脏功能障碍状态。相比之下,一组接受T4和CoQ10(5毫克/千克)联合治疗3周,NE和ATP没有降低(分别为0.9±0.2微克/克湿重和44.6±1.9纳摩尔/毫克蛋白),并防止了线粒体Ca2+含量增加(18.2±1.2纳摩尔/毫克蛋白)。一组用CoQ10(5毫克/千克)治疗3周,心肌NE、ATP和线粒体Ca2+含量没有变化。这些结果表明,外源性给予CoQ10可能预防甲状腺毒症性心脏病中的生化紊乱。